Sofenib Tablet 200 mg contains Sorafenib Tosylate, an oral multikinase inhibitor used in the treatment of various advanced cancers, including hepatocellular carcinoma (liver cancer), renal cell carcinoma (kidney cancer), and certain types of thyroid cancer.

Sorafenib works by blocking multiple protein kinases involved in tumor cell proliferation and angiogenesis (formation of new blood vessels), thereby slowing cancer growth and reducing tumor progression. It is particularly useful for patients with advanced or unresectable cancers where conventional treatments may be limited.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Key Features and Benefits

• Active Ingredient: Sorafenib Tosylate 200 mg

• Primary Use: Management of advanced cancers (liver, kidney, and thyroid)

• Mechanism of Action: Inhibits tumor cell proliferation and angiogenesis by targeting multiple kinases

• Formulation: Oral tablet for convenient daily dosing

• Targeted Cancer Therapy: Slows tumor growth and progression in advanced malignancies

Benefits

• Reduces tumor progression and spread in advanced cancers

• Targets both tumor cells and tumor blood supply for comprehensive action

• Oral formulation allows home-based administration under supervision

• Can be combined with other therapies as part of a cancer management plan

• Supports improved patient outcomes in advanced-stage cancers

Recommended Dosage

• Adults: Typically 400 mg twice daily (200 mg tablets ×2) or as prescribed by an oncologist

• Tablets should be taken on an empty stomach, at least one hour before or two hours after meals

• Dose adjustments may be necessary in cases of side effects, liver impairment, or drug interactions

• Regular monitoring of liver function, kidney function, and blood counts is recommended

Important: Do not stop or alter dosage without consulting an oncologist.

Safety Information

Sofenib Tablet 200 mg may cause side effects, including:

• Common effects: Fatigue, diarrhea, hand-foot skin reaction, rash, nausea, loss of appetite

• Serious effects: Hypertension, liver toxicity, bleeding, cardiovascular events, severe skin reactions

• Precautions: Use with caution in patients with liver or kidney impairment, cardiovascular disease, or risk of bleeding. Regular laboratory monitoring and follow-up with a healthcare professional are essential

Patients should report unusual bleeding, severe rash, or sudden health changes immediately.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Storage

Store Sofenib Tablet 200 mg in a cool, dry place, away from light and moisture. Keep out of reach of children. Proper storage ensures the tablet’s stability and effectiveness.

Conclusion

Sofenib Tablet 200 mg by SK Pharma is a targeted oral therapy for advanced cancers, including liver, kidney, and thyroid malignancies. By inhibiting tumor cell growth and angiogenesis, it helps slow disease progression and supports improved clinical outcomes for patients with advanced-stage cancer.